logo-loader

Redfund Capital bolsters board with appointment of cannabis-trailblazer

Published: 11:29 06 Sep 2018 EDT

cannabis plant
Newly appointed board member de Freitas specializes in Canadian cannabis legislation

Promising news from Redfund Capital Corp (CSE:LOAN) as it announced Thursday it has boosted its board with the appointment of cannabis-trailblazer, Amanda de Freitas. 

Based in Toronto, de Freitas is a regulatory compliance executive and lobbyist and specializes in Canadian cannabis legislation. She is the chief executive officer of Cannaceutical Canada Ltd., a management consulting firm that focuses on global medical cannabis supply transactions and deal development.

"Amanda has become a trailblazer in the Canadian cannabis sector. She has ushered many start-ups in the cannabis space from simple visions to legalization and strong revenues. She continues to be the female voice to many women in Canada who are quietly becoming global players in the cannabis sector," said chief executive officer, Meris Kott.

"On behalf of our entire board, it is our pleasure to welcome another woman of weed to the capital markets and Redfund."

READ: Redfund Capital completes US$3mln investment into Colombian cannabis group Biominerales

Ms. de Freitas is also president and founder of CannaBizSolutions Company, a firm that's primary focus is on domestic medical and adult use cannabis businesses, helping assist them with their regulatory compliance, licensing, corporate and product development strategies. She is a frequent panelist and speaker at Canadian Medical Cannabis conferences.

The company also noted that Jack Bal has stepped down from his position on the board of directors. 

Shares of Redfund were at C$0.35 in Toronto. 

Buds & Duds: Cannabis stocks slump Tuesday; Redfund Capital shares jump as...

Buds today are Redfund Capital Corp (CSE:LOAN) (OTCMKTS:PNNRF), OrganiGram Holdings Inc (OTCMKTS:OGRMF) (CVE:OGI), the duds taking a hit are Tilray Inc (NASDAQ:TLRY), Sunniva Inc (CSE:SNN) (OTCQB:SNNVF). 

on 04/30/2019